Autonomix Medical, Inc.
Nasdaq · CIK 0001617867 · Fiscal year end 0331
Latest reported period: Latest published period
Revenue
$0
Operating Income
$-17.0M
Net Income
$-16.7M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-17.0M | - | - |
| Net Income | $-16.7M | - | - |
| Eps Basic | -2.32 | - | - |
| Cash And Equivalents | $7.0M | - | - |
| Total Assets | $7.6M | - | - |
| Total Liabilities | $1.7M | - | - |
| Shareholders Equity | $5.9M | - | - |
| Operating Cash Flow | $-12.3M | - | - |
| Capital Expenditures | $10,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-K | Autonomix Medical, Inc. | 2026-05-27 | 0001437749-26-018573 |
| 10-Q | Autonomix Medical, Inc. | 2026-02-11 | 0001437749-26-003816 |
| 10-Q | Autonomix Medical, Inc. | 2025-11-12 | 0001437749-25-034517 |
| 10-Q | Autonomix Medical, Inc. | 2025-08-13 | 0001437749-25-026564 |